Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Posttraumatic Headache, Mild Traumatic Brain Injury

In brief

This study aims to assess the effect and safety of erenumab compared to placebo for the treatment of acute posttraumatic headache (PTH) in military service members and civilians with mild traumatic brain injury (mTBI).

Key facts

Study ID
NCT05049057
Run by
Henry M. Jackson Foundation for the Advancement of Military Medicine
People needed
404
Starts
2022-07-19
Expected to finish
2027-05-19
Last updated by the study team
2024-02-22

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.